Dr. David E. Mann Jr., MD

Dr. Mann practices at Andalusia Health in Andalusia, Alabama, part of ScionHealth.

Dr. Mann's NPI, 1366425670, was assigned on November 22, 2005. Dr. Mann graduated from Drexel University College Of Medicine in 1991. Dr. Mann holds Florida license ME0072939.

Dr. Mann's primary practice is Andalusia Health, at 849 South Three Notch Street, Andalusia, AL 36420 in Covington County. The practice phone is (334) 222-8466.

Dr. Mann's primary practice is Andalusia Health in Andalusia, Alabama, part of ScionHealth. Dr. Mann is also affiliated with Ascension Sacred Heart Pensacola. The medical group on file is Sacred Heart Medical Group. Dmand AI also links Dr. Mann to 3 more hospitals, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mann practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mann's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mann is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Mann's licenses on file in 3 states: Florida, Alabama and Pennsylvania.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Mann treats.

CMS data shows 719 Medicare services from Dr. Mann across 5 procedure codes in 2024, all of them office visits, for 282 Medicare patients. Medicare paid $44,518 for them. Every service was in an office.

CMS counts 282 Medicare patients who saw Dr. Mann in 2024. The largest group is 65 to 74, with 122 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mann's median patient age at 70, with 62% women.

In 2024, Dr. Mann wrote 1,402 Medicare Part D claims for 216 patients. 84% of them were for generic drugs. CMS names the drug for 1,038 of them, across 32 drugs with 11 or more claims each, at $1,572,901 in total drug cost. In 2023, CMS named 1,217 claims across 38 drugs.

Dr. Mann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Mann, published from 2007 to 2011. The most frequent topics are Alzheimer Disease, Brain and Genetic Predisposition to Disease. Dr. Mann has published most often in Neurosci Lett. Dr. Mann's most frequent co-authors are David M. Mann, DO, David Austin Craig, MD and Steven T. Dekosky, MD.

CMS Open Payments shows 659 general payments to Dr. Mann from 61 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. AstraZeneca Pharmaceuticals LP paid the most, $38,741.

Dr. Mann graduated from Drexel University College Of Medicine in 1991. Dr. Mann is a member of ASCO.

Dr. Mann is in network with 9 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.